Envy Medical emerged in the field of dermatology and medical aesthetics as a medical device and skin care leader with a strong culture in innovation and a solid reputation for clinically-backed, scientifically-proven products. Envy Medical partnered with Stanford University to develop and patent the Lumixyl peptide (Decapeptide-12). Scientifically researched and clinically proven, Lumixyl reduces hyperpigmentation sun spots, age spots, hormonally-induced hyperpigmentation and PIH without irritation. Lumixyl is the cornerstone of Envy Medical’s skin brightening strategy, and stands as a groundbreaking discovery in the desire for safe, efficacious, and successful treatment of hyperpigmentation.
Lumixyl™ 由史丹福大學皮膚科權威 Dr.Basil Hantash 研發，透過 20 年於淡斑亮肌經驗，創出一套強效淨白淡斑護膚組合，高效改善色斑、痘印、暗啞及膚色不均之問題。
